Gossamer Bio, Inc. (GOSS)
2.52
+0.07
(+2.86%)
USD |
NASDAQ |
Jan 16, 16:00
2.60
+0.08
(+3.17%)
After-Hours: 20:00
Gossamer Bio EPS Diluted (Quarterly): -0.2115 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -5.079 |
| XOMA Royalty Corp. | 0.6991 |
| Rezolute, Inc. | -0.1755 |
| Axsome Therapeutics, Inc. | -0.9442 |
| Crinetics Pharmaceuticals, Inc. | -1.381 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -48.22M |
| Revenue (Quarterly) | 13.29M |
| Total Expenses (Quarterly) | 61.52M |
| Enterprise Value | 605.92M |
| Gross Profit Margin (Quarterly) | 98.35% |
| Profit Margin (Quarterly) | -362.7% |
| Earnings Yield | -27.27% |
| Normalized Earnings Yield | -26.36 |